Publications by authors named "Junryo Rii"

Claim this Profile
G
Genetic and clinical characteristics of Japanese cystinuria with exon and exon-intron boundary variants.
Shinichi Sakamoto, Yukio Naya, Junryo Rii, Kazumi Taguchi, Masaaki Fujimura

Sci Rep· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial report of prospective study of regional cooperation for imaging-based follow-up after curative renal cell carcinoma surgery.
Ryo Tsukamoto, Tomokazu Sazuka, Hiroaki Sato, Takayuki Arai, Manato Kanesaka, Junryo Rii

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The LAT1 inhibitor JPH203 suppresses the growth of castration-resistant prostate cancer through a CD24-mediated mechanism.
Shinpei Saito, Keisuke Ando, Shinichi Sakamoto, Minhui Xu, Yasutaka Yamada, Junryo Rii

Cancer Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix.
Shuhei Kamada, Shinichi Sakamoto, Ryo Kinoshita, Xue Zhao, Tomohiko Kamasako, Rii Junryo

Prostate· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
L-type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel-resistant prostate cancer by inhibiting cyclin-dependent kinase activity.
Junryo Rii, Shinichi Sakamoto, Atsushi Mizokami, Minhui Xu, Ayumi Fujimoto

Cancer Sci· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copy Number Gain in Androgen Receptors Predicts the Poor Prognosis in Japanese Castration-resistant Prostate Cancer.
Shinichi Sakamoto, Keisuke Ando, Sangjon Pae, Xue Zhao, Kazuko Sakai, Junryo Rii

Anticancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of the prognostic nutritional index in patients with metastatic hormone-sensitive prostate cancer: A retrospective, multicenter, cohort study.
Yasutaka Yamada, Shinichi Sakamoto, Kodai Sato, Shinpei Saito, Manato Kanesaka, Junryo Rii

Prostate· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor localization by Prostate Imaging and Reporting and Data System (PI-RADS) version 2.1 predicts prognosis of prostate cancer after radical prostatectomy.
Ayumi Fujimoto, Shinichi Sakamoto, Takuro Horikoshi, Xue Zhao, Yasutaka Yamada, Junryo Rii

Sci Rep· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Location and a Tumor Volume over 2.8 cc Predict the Prognosis for Japanese Localized Prostate Cancer.
Haruki Baba, Shinichi Sakamoto, Xue Zhao, Yasutaka Yamada, Junryo Rii

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revision of CHAARTED and LATITUDE criteria among Japanese de novo metastatic prostate cancer patients.
Manato Kanesaka, Shinichi Sakamoto, Yasutaka Yamada, Junryo Rii, Maihulan Maimaiti

Prostate Int· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional analysis of LAT3 in prostate cancer: Its downstream target and relationship with androgen receptor.
Junryo Rii, Shinichi Sakamoto, Masahiro Sugiura, Manato Kanesaka, Ayumu Fujimoto

Cancer Sci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors influencing overall survival in de novo oligometastatic prostate cancer patients.
Junryo Rii, Shinichi Sakamoto, Yasutaka Yamada, Nobushige Takeshita, Satoshi Yamamoto

Prostate· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of an inflammatory index for patients with metastatic castration-resistant prostate cancer.
Yasutaka Yamada, Shinichi Sakamoto, Junryo Rii, Satoshi Yamamoto, Shuhei Kamada

Prostate· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How many bone metastases may be defined as high-volume metastatic prostate cancer in Asians: A retrospective multicenter cohort study.
Yasutaka Yamada, Shinichi Sakamoto, Junryo Rii, Satoshi Yamamoto, Shuhei Kamada

Prostate· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma.
Maihulan Maimaiti, Shinichi Sakamoto, Yasutaka Yamada, Masahiro Sugiura, Junryo Rii

Sci Rep· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Oncogene and tumor suppressor gene for prostate cancer].
Takeshi Ueda, Atsushi Komaru, Jun-ryo Rii, Masayuki Kobayashi, Satoshi Fukasawa

Nihon Rinsho· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis